Results 161 to 170 of about 6,845,162 (410)

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias   +12 more
wiley   +1 more source

Nurse Researchers in Children\u27s Hospitals [PDF]

open access: yes, 2010
Little is known about the role of nurse researchers (NRs) and the structure of nursing research programs in children\u27s hospitals in the United States. This descriptive study obtained survey data from 33 NRs.
Balchunas, Mary Kay   +12 more
core   +1 more source

Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014

open access: yesJournal of the American Medical Association (JAMA), 2017
C. Rhee   +19 more
semanticscholar   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

open access: yesMolecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach   +8 more
wiley   +1 more source

Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002

open access: yesPublic health reports (1974), 2007
R. M. Klevens   +6 more
semanticscholar   +1 more source

GUY'S HOSPITAL. [PDF]

open access: green, 1888
Hale White
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

open access: yesMolecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche   +8 more
wiley   +1 more source

The Hospice Friendly Hospitals Programme [PDF]

open access: yes, 2014
This report describes how care for people who die in Irish hospitals is planned and provided for; and how those processes evolved over the period 2007-2013. The report details a journey and we do not claim to have reached journey's end.
Kathy Walsh
core  

Home - About - Disclaimer - Privacy